Area of research
Genetics · Epidemiology
Research interest
Research interests include Medicine, Adalimumab, Internal medicine, Crohn's disease, Gastroenterology, and Infliximab.
Adalimumab Induces Deep Remission in Patients With Crohn's Disease
Adalimumab Therapy Is Associated With Reduced Risk of Hospitalization in Patients With Ulcerative Colitis
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial
Comparison of medical costs among patients using adalimumab and infliximab: A retrospective study (COMPAIRS)